Al Hammadi Holding operates two hospitals in Riyadh, comprising 600 inpatient beds and 220 outpatient clinics as of 2025. In H1 2026, the company recorded revenues of $171 million, driven primarily by 21% pharmaceutical segment growth, and had assets worth $770 million. In January 2026, it signed a $14.5 million agreement with AC Milan to establish MilanLab sports medicine and rehabilitation centers within Al Hammadi Hospitals Group. Mohammed Al Hammadi holds a 4.9% stake in the company, which was cofounded by Abdulaziz Al Hammadi in 1985, who remains its chairman and largest shareholder with a 17% stake. Al Hammadi is also chairman of Al-Baha Investment and Development.